Lily Zhong

Lily Zhong currently serves as the Manager of Finance R&D at Supernus Pharmaceuticals, Inc., a biopharmaceutical company specializing in treatments for central nervous system diseases, since April 2022. Prior to this role, Lily worked as an Accounting Manager at OpGen, Inc. from May 2016 to April 2022, where significant contributions included transferring accounting functions during a leadership transition. Earlier experience includes positions as a Staff Accountant at Telnet, Inc. and Benjamin & Associates, Inc. (CPA Firm), and as an Associate Accountant at the Toronto Transit Commission. Lily holds a Master’s degree in Accounting and Finance from the University of Maryland Global Campus, a Bachelor of Science in Accounting from the University of Maryland University College, and an Advanced Diploma in Business Administration with a focus on Accounting from Centennial College.